Aaron's Feed
Sep 28, 2010

AkzoNobel keeps target, to focus on emerging markets

LONDON, Sept 28 (Reuters) – AkzoNobel (AKZO.AS: Quote, Profile, Research, Stock Buzz), the world’s
biggest paint maker, turned down the chance to raise its
five-year margin target, saying it would boost market share and
increase sales as it looks to emerging markets for growth.

The maker of brands Dulux, Sikkens and Glidden has, which
has almost completed the integration of British paints firm ICI,
said it would target 20 billion euros ($26.69 billion) in sales
and expects 50 percent of this will come from emerging
economies, such as India and Brazil.

Sep 27, 2010

AkzoNobel to focus on emerging markets growth

AMSTERDAM, Sept 27 (Reuters) – Dutch paints group AkzoNobel
(AKZO.AS: Quote, Profile, Research, Stock Buzz) will likely follow other chemicals firms in focusing
on emerging markets growth at its strategy day on Tuesday, while
investors are anxious about its North American business.

AkzoNobel, which shut factories and cut jobs after buying
British paints firm ICI in 2008, said in July it had met its 14
percent earnings before interest, depreciation and amortisation
(EBITDA) margin target a year ahead of schedule and now aims to
update investors about its strategy and targets.

Sep 24, 2010

Dutch investor says Crucell buyout “not done deal”

AMSTERDAM (Reuters) – An offer for Crucell from U.S. healthcare company Johnson & Johnson was “not a done deal,” Delta Lloyd Asset Management said after another top shareholder in the Dutch biotechnology firm heightened its resistance to a possible deal.

Regulatory filings earlier on Friday showed the Van Herk Group, which has criticized J&J’s $2.3 billion offer for Crucell company as “meager and too early,” has increased its stake since the potential bid was announced last week.

Sep 23, 2010

Benelux chems DSM, Solvay look east for growth

AMSTERDAM/BRUSSELS, Sept 23 (Reuters) – Dutch chemicals
maker DSM (DSMN.AS: Quote, Profile, Research, Stock Buzz) unveiled plans for a push into Asia just as
rival Belgian Solvay cut 800 jobs, underscoring the urgent need
to counter anaemic growth in the sector’s European home market.

DSM has bought and sold operations over the past 10 years to
exit bulk chemicals and move into niche life sciences, nutrition
and performance materials, while Solvay sold its drugs unit in
February to focus on innovative chemicals and plastics products.

Sep 23, 2010

DSM targets improved core profit after overhaul

AMSTERDAM, Sept 23 (Reuters) – Dutch chemicals group DSM
(DSMN.AS: Quote, Profile, Research, Stock Buzz) set ambitious core profit and sales growth targets, on
Thursday betting its exposure to fast-growing emerging markets
and planned acquisitions will keep potential predators at bay.

For the past decade, DSM has offloaded or bought operations
to exit bulk chemicals and move into niche, higher margin life
sciences, nutrition and performance materials and more recently
enzyme technology to become less prone to economic downturns.

Sep 20, 2010

Mladic arrest vital for war crimes courts: prosecutor

THE HAGUE (Reuters) – Failure to arrest fugitive Serbian general Ratko Mladic could undermine the work of war crimes tribunals after the U.N.’s Yugoslavia tribunal wraps up its work in three years, its chief prosecutor said Monday.

Mladic is one of two suspects still on the run from the International Criminal Tribunal for the former Yugoslavia (ICTY), set up by the U.N. to prosecute war crimes committed during the violent break-up of the Balkans state in the 1990s.

Sep 20, 2010

Dutch arrest British terrorism suspect at Schiphol

AMSTERDAM (Reuters) – Dutch military police arrested a British man of Somali descent at Amsterdam’s Schiphol Airport on Sunday morning on suspicion of links to terrorism, the Dutch public prosecutor said.

The prosecutor said in a statement that police were investigating whether the man, who flew through Schiphol on his way from Liverpool in northern England to Entebbe in Uganda, had connections to a foreign militant organization.

Sep 19, 2010

Dutch arrest terrorism suspect at Schiphol

AMSTERDAM (Reuters) – Dutch military police arrested a British man of Somali descent at Amsterdam’s Schiphol Airport on Sunday morning on suspicion of links to terrorism, the Dutch public prosecutor said.

The prosecutor said in a statement that police were investigating whether the man, who had flown from the northern English city of Liverpool and was traveling through Schiphol on his way to Entebbe in Uganda, had connections to a foreign militant organization.

Sep 17, 2010

Johnson & Johnson aims to buy vaccine maker Crucell

AMSTERDAM (Reuters) – U.S. health care company Johnson & Johnson, looking to catapult itself into the global vaccine market, is in talks to pay 1.75 billion euros (1.46 billion pounds) to buy Dutch biotech Crucell.

J&J, which already owns a 17.9 percent stake in vaccine maker Crucell, said on Friday its potential cash offer valued Crucell shares at 24.75 euros, a 58 percent premium to Thursday’s closing price.

Sep 17, 2010

Johnson & Johnson aims to buy out Crucell

AMSTERDAM (Reuters) – U.S. health care company Johnson & Johnson (JNJ.N: Quote, Profile, Research, Stock Buzz) is in talks to pay 1.75 billion euros ($2.3 billion) for the shares in Dutch biotech Crucell (CRCL.AS: Quote, Profile, Research, Stock Buzz) it does not already own to strengthen its vaccine business.

Johnson and Johnson, which already owns a 17.9 percent stake in vaccine maker Crucell, said on Friday its potential cash offer would value Crucell shares at 24.75 euros, a 58 percent premium to Thursday’s closing price.

    • About Aaron

      "Aaron specialises in the chemical and biotech sectors in the Netherlands alongside daily equities and general news reporting duties. He also covers the international criminal courts from The Hague. He began his career as a newspaper reporter and sub-editor in Australia in 1994. He has lived in the Netherlands since March 2000."
    • Follow Aaron